These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8990663)

  • 1. The effects of therapy with rifampicin and isoniazid on basic investigations for Cushing's syndrome.
    Zawawi TH; al-Hadramy MS; Abdelwahab SM
    Ir J Med Sci; 1996; 165(4):300-2. PubMed ID: 8990663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
    Görges R; Knappe G; Gerl H; Ventz M; Stahl F
    J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
    Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy.
    Kyriazopoulou V; Vagenakis AG
    J Clin Endocrinol Metab; 1992 Jul; 75(1):315-7. PubMed ID: 1619024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal dexamethasone suppression tests in a rifampicin-treated patient with suspected Cushing's syndrome.
    Abdullah HN; Nowalid WK
    Endokrynol Pol; 2010; 61(6):706-9. PubMed ID: 21104646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
    Montwill J; Igoe D; McKenna TJ
    Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome.
    Kennedy L; Atkinson AB; Johnston H; Sheridan B; Hadden DR
    Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1188-91. PubMed ID: 6437479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.
    Meikle AW
    Clin Endocrinol (Oxf); 1982 Apr; 16(4):401-8. PubMed ID: 7094363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of endocrine tests. B: screening for hypercortisolism.
    Holleman F; Endert E; Prummel MF; van Vessem-Timmermans M; Wiersinga WM; Fliers E
    Neth J Med; 2005 Oct; 63(9):348-53. PubMed ID: 16244382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
    Findling JW; Raff H; Aron DC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
    Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
    Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
    Yaneva M; Mosnier-Pudar H; Dugué MA; Grabar S; Fulla Y; Bertagna X
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3345-51. PubMed ID: 15240613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.